Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
LYRM2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
CEPT1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
LOC102724965 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
RGS20 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF503-AS2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SULF1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ST8SIA5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GBX1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RPS27L - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SIGLECL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CFC1B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IL22RA1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PLCL2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SERP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LRRC10B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LRRD1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on